MedTrace Logo

Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI

NCT04606082 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-10-28

No results posted yet for this study

Summary

Intrauterine Granulocyte colony stimulating factor (GCSF) was compared with intrauterine Human Chorionic Gonadotropin (HCG) in increasing clinical pregnancy rate as a primary outcome and ultrasound imaging of gestational sac as a secondary outcome.

Conditions

  • Fertility Disorders

Interventions

DRUG

Granulocyte Colony Stimulated Factor

GCSF was intrauterine injected once at ovum pick up day

DRUG

Human Chorionic Gonadotropins

500 IU of HCG was injected intrauterine once at ovum pick up day

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Elsayed Eldesouky · Assistant professor of obstetrics and gynecology faculty of medicine Alazhar university Cairo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-30
Primary Completion
2021-01-10
Completion
2021-01-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04606082 on ClinicalTrials.gov